Advertisement
Screener

HYPERION DEFI, INC. (HYPD) Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration

HYPERION DEFI, INC. Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration

HYPERION DEFI, INC. (HYPD) had Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration of $3.20 million as of 2025-12-31, per its 10-K filed 2026-03-30.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Alternative

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration · last filed 2026-03-30

  • 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $3.20M.
  • 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $10.80M.
  • 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $10.80M.
  • 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration $10.80M.
Period endDeferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration
2025-12-31$3.20M
10-K · filed 2026-03-30
2024-12-31$10.80M
10-K · filed 2025-04-15
2023-12-31$10.80M
10-K · filed 2024-03-18
2022-12-31$10.80M
10-K · filed 2023-03-31
2021-12-31$10.80M
10-K · filed 2022-03-30
2020-12-31$10.80M
10-K · filed 2021-03-30
2019-12-31$10.80M
10-K · filed 2020-03-30
2018-12-31$10.80M
10-K · filed 2019-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76